Cargando…

Heterotopic lung transplant: a feasible approach to compensate for organ shortages

Lung transplants are still limited by the shortage of suitable donor lungs, especially during the coronavirus disease 2019 pandemic. A heterotopic lung transplant (HLTx), as a flexible surgical procedure, can maximize the potential of donor lungs in an emergency, but its widespread use is hindered b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jin, Ye, ShuGao, Liu, Feng, Huang, Man, Xu, Yongshan, Chen, Yuan, Chen, JingYu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336561/
https://www.ncbi.nlm.nih.gov/pubmed/35642887
http://dx.doi.org/10.1093/icvts/ivac156
_version_ 1784759565294764032
author Zhao, Jin
Ye, ShuGao
Liu, Feng
Huang, Man
Xu, Yongshan
Chen, Yuan
Chen, JingYu
author_facet Zhao, Jin
Ye, ShuGao
Liu, Feng
Huang, Man
Xu, Yongshan
Chen, Yuan
Chen, JingYu
author_sort Zhao, Jin
collection PubMed
description Lung transplants are still limited by the shortage of suitable donor lungs, especially during the coronavirus disease 2019 pandemic. A heterotopic lung transplant (HLTx), as a flexible surgical procedure, can maximize the potential of donor lungs in an emergency, but its widespread use is hindered by difficulties in anastomosis and paucity of outcome data. We performed a retrospective review of 4 patients, each of whom received an HLTxs over 1 year, including 1 left-to-right single HLTx, 2 right-to-left single HLTxs and 1 lobar HLTx (right upper lobe-to-left). The median recipient age was 58.5 years (46–68); 3 patients were male. The postoperative hospital stay was 33 days (30–42). One recipient lived for 10 years and died of bronchiolitis obliterans syndrome; the others were alive with no major morbidity at 12 to 31 months after the operation with a 1-year survival of 100%. The follow-up chest images showed that transplanted lungs could be inflated well and adapted morphologically to fill the thoracic cavity in the short and long term. This study demonstrates that an HLTx is a feasible alternative to a conventional lung transplant in emergency cases and could be considered in selected patients at advanced medical centres.
format Online
Article
Text
id pubmed-9336561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93365612022-07-29 Heterotopic lung transplant: a feasible approach to compensate for organ shortages Zhao, Jin Ye, ShuGao Liu, Feng Huang, Man Xu, Yongshan Chen, Yuan Chen, JingYu Interact Cardiovasc Thorac Surg Thoracic Lung transplants are still limited by the shortage of suitable donor lungs, especially during the coronavirus disease 2019 pandemic. A heterotopic lung transplant (HLTx), as a flexible surgical procedure, can maximize the potential of donor lungs in an emergency, but its widespread use is hindered by difficulties in anastomosis and paucity of outcome data. We performed a retrospective review of 4 patients, each of whom received an HLTxs over 1 year, including 1 left-to-right single HLTx, 2 right-to-left single HLTxs and 1 lobar HLTx (right upper lobe-to-left). The median recipient age was 58.5 years (46–68); 3 patients were male. The postoperative hospital stay was 33 days (30–42). One recipient lived for 10 years and died of bronchiolitis obliterans syndrome; the others were alive with no major morbidity at 12 to 31 months after the operation with a 1-year survival of 100%. The follow-up chest images showed that transplanted lungs could be inflated well and adapted morphologically to fill the thoracic cavity in the short and long term. This study demonstrates that an HLTx is a feasible alternative to a conventional lung transplant in emergency cases and could be considered in selected patients at advanced medical centres. Oxford University Press 2022-06-01 /pmc/articles/PMC9336561/ /pubmed/35642887 http://dx.doi.org/10.1093/icvts/ivac156 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Thoracic
Zhao, Jin
Ye, ShuGao
Liu, Feng
Huang, Man
Xu, Yongshan
Chen, Yuan
Chen, JingYu
Heterotopic lung transplant: a feasible approach to compensate for organ shortages
title Heterotopic lung transplant: a feasible approach to compensate for organ shortages
title_full Heterotopic lung transplant: a feasible approach to compensate for organ shortages
title_fullStr Heterotopic lung transplant: a feasible approach to compensate for organ shortages
title_full_unstemmed Heterotopic lung transplant: a feasible approach to compensate for organ shortages
title_short Heterotopic lung transplant: a feasible approach to compensate for organ shortages
title_sort heterotopic lung transplant: a feasible approach to compensate for organ shortages
topic Thoracic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336561/
https://www.ncbi.nlm.nih.gov/pubmed/35642887
http://dx.doi.org/10.1093/icvts/ivac156
work_keys_str_mv AT zhaojin heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages
AT yeshugao heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages
AT liufeng heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages
AT huangman heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages
AT xuyongshan heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages
AT chenyuan heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages
AT chenjingyu heterotopiclungtransplantafeasibleapproachtocompensatefororganshortages